Clinical Trials Logo

Clinical Trial Summary

The main objective of this study was to evaluate the 5-day kinetics of plasma paracetamol levels in postoperative major hepatic surgery (resection greater than or equal to three hepatic segments) compared with less extensive liver resection and hepatic re-intervention. The clearance of indocyanine green is a marker of hepatic perfusion but also of the proper hepatocyte functioning, if hemodynamic conditions are stable.

Some patients may be operated on up to four or five times in the liver. Moreover, these patients probably present an increased risk of postoperative hepatocellular insufficiency due to a quantitative and qualitative decrease in their hepatic parenchyma. It is therefore interesting to evaluate the use of paracetamol in this situation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03297073
Study type Interventional
Source University Hospital, Lille
Contact Gilles Lebuffe, MD,PhD
Phone 3 20 44 41 12
Email gilles.lebuffe@chru-lille.fr
Status Recruiting
Phase N/A
Start date December 20, 2016
Completion date January 2020

See also
  Status Clinical Trial Phase
Completed NCT05593211 - Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures N/A
Terminated NCT02104154 - Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting N/A
Not yet recruiting NCT06153394 - Prolonged Hypercoagulability Following Major Liver Resection for Malignancy Phase 3
Completed NCT03652636 - Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions Phase 4
Recruiting NCT05822635 - SpyGlass Surgical Study
Not yet recruiting NCT05616442 - Ketotifen in Non-Alcoholic Fatty Liver Disease Patients Phase 4
Completed NCT03767517 - A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders N/A